KPV-31320-20707 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-21
Dose 1 — Pfizer-BioNTech
2022-06-27
Registered in v-safe
2022-06-27
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: Rhinorrhoea — Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetite · Be unable to do your normal daily activities

Free text: Runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-06-29
Health check-in — day 7, dose 1, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-07-08
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-12
Dose 2 — Pfizer-BioNTech
2022-07-26
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-02
Health check-in — day 21, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-08-09
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-17
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-23
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-17
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-21	Pfizer-BioNTech	No
2	2022-07-12	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — days 1–6 daily, dose 1, under 3

2022-06-27

Systemic reaction (other): Runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release